# 119-hr-3269: ETHIC Act

119-hr-3269, ETHIC Act, is a 119th Congress bill sponsored by Rep. Arrington, Jodey C. [R-TX-19] (R-TX); status introduced (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-3269
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-3269
- Congress: 119
- Title: ETHIC Act
- Status: introduced
- Introduced: 2025-05-08
- Sponsor: Rep. Arrington, Jodey C. [R-TX-19] (R-TX)
- Cosponsors: 9
- Policy area: Commerce
- Touches household money: no
- Last recorded action: 2026-09-21

## Summary

**This bill would limit patent owners to asserting at most one patent per "Patent Group" against a generic or biosimilar applicant or product holder, aiming to cut through patent "thickets" that delay competition.** - Generic and biosimilar applicants and holders would face fewer parallel patent suits. The limit applies to applications under section 505(b)(2) or 505(j) of the Federal Food, Drug, and Cosmetic Act and to licensure under section 351(k) of the Public Health Service Act submitted on or after enactment. - Patent owners could no longer bring multiple infringement actions over different patents in the same Patent Group against the same party. They would be restricted to one asserted patent per Patent Group for each targeted party. - Courts and litigants would use a new "Patent Group" definition based on disclaimers under 35 U.S.C. 253 to determine which patents count together. That groups commonly owned patents or applications that reference one another via disclaimers.

## Cosponsors (9)

- Rep. Doggett, Lloyd [D-TX-37] (D-TX), 2025-05-08T00:00:00.000Z
- Rep. Issa, Darrell [R-CA-48] (R-CA), 2025-05-08T00:00:00.000Z
- Rep. Jayapal, Pramila [D-WA-7] (D-WA), 2025-05-08T00:00:00.000Z
- Rep. Pfluger, August [R-TX-11] (R-TX), 2025-05-08T00:00:00.000Z
- Rep. Dingell, Debbie [D-MI-6] (D-MI), 2025-05-09T00:00:00.000Z
- Rep. Tlaib, Rashida [D-MI-12] (D-MI), 2025-07-29T00:00:00.000Z
- Rep. Harshbarger, Diana [R-TN-1] (R-TN), 2026-04-06T00:00:00.000Z
- Rep. García, Jesús G. "Chuy" [D-IL-4] (D-IL), 2026-04-20T00:00:00.000Z
- Rep. Craig, Angie [D-MN-2] (D-MN), 2026-06-23T00:00:00.000Z

## Provisions PRIA read

- Caps patent claims in drug lawsuits: benefit, medium. If enacted, in certain drug and biologic patent cases, a plaintiff would be limited to one patent per "Patent Group" against a covered party. A Patent Group would mean commonly owned patents tied together by a formal patent disclaimer. The limit would cover generic or follow-on drug and biosimilar…

## Related bills

- 119-hr-1: One Big Beautiful Bill Act
- 119-hr-9877: Health Equity and Accountability Act of 2026
- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-hr-1502: North Platte Canteen Congressional Gold Medal Act
- 119-hr-452: Miracle on Ice Congressional Gold Medal Act

## Sources
- [119-hr-3269 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/3269)

## Related
- [119-hr-1: One Big Beautiful Bill Act](https://policyrisk.com/legislation/119-hr-1)
- [119-hr-9877: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-hr-9877)
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [119-hr-1502: North Platte Canteen Congressional Gold Medal Act](https://policyrisk.com/legislation/119-hr-1502)
- [119-hr-452: Miracle on Ice Congressional Gold Medal Act](https://policyrisk.com/legislation/119-hr-452)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-3269 (as of 2026-09-21).